Tagged with regulatory

Pharma Prof. Thierry Philip, President of Institut Curie, is proud of the model that the institute is thriving for: excellent science and research in all forms, from the most basic to applied clinical medicine. As a Cancer Biology Center, it is not only one of the top institutes in France, but…

Pharmaceuticals Marius Fourie highlights implications of the recent merger between the company’s two subsidiaries and the unparalleled levels of value and service the consolidated organization will offer. He also illustrates the affiliate’s strategies in navigating the country’s dual-model healthcare system and the ways in which effective education and training can benefit all stakeholders…

Pharma Pasquale Frega, General Manager for Celgene Italy, discusses the company’s rapid growth and imminent entry into immunology, the business and regulatory environment for innovators in the country and the characteristics of the Italian market that make it especially promising to Celgene. Mr. Frega, to start off, Imnovid, Celgene’s newest oral treatment…

Pharma Dr. Costas Piliounis discusses the importance of containing diabetes, the dampening effects budget ceilings have on companies’ performance and growth potential, as well as the positive influence which changes currently being implemented in the regulatory system will have on the industry moving forward.   Dr. Piliounis, to start off, you…

Pharma A leading consultant to IMS and Professor at Paris Dauphine University reveals how the French healthcare system is moving in two main strategic directions: increasingly relying on private funding through complementary health insurance, and breaking with the egalitarian principle that everybody should be reimbursed to the same extent irrespective of…

Pharma Anita Atema, General Manager of Celgene, reveals Celgene’s inspiring and concrete  initiatives that illustrate how a true willingness to cooperate with healthcare stakeholders and a remarkable effort of transparency can help to tackle the current difficulties in accessing the Dutch market, while implementing new innovative pricing models such as pay for benefit.…

Pharma Anna Van Poucke, Partner and Chairman at KPMG Healthcare in the Netherlands, explains how KPMG can helps its partners and clients move forward towards a better integrated, more efficient and smartly designed healthcare eco-system, while remaining at the forefront of the industry in terms of M&A, supply chain and cultural…

Pharma Alberto Gugliemo, President of the Carlo Besta Institute in Milan, shares the changing perception of neurological diseases and neurological science in Italy, the nature of the institute’s collaboration with the industry and the importance of easing regulations surrounding the hire of scientists. As president of Italy’s leading scientific institute for…

Pharma Francesco Carugi, Managing Director at Grifols Italy, discusses the company’s presence in the plasma, plasma products and plasma diagnostics segments, the impact of the liberalization of the Italian plasma market on their growth and business model and his commitment to driving change management to develop the affiliate’s future success. Grifols is…

Pharma As the founder of Egypt’s leading commercial agent for advanced medical technologies, Mahmoud Bagneid has a simple goal for Egyptian healthcare; for all Egyptian’s to be aware that they should have a yearly heath checkup, and to have regular basic blood tests to diagnose diabetes, hypertension, and other common health…

Pharma Daniel de Labauve d’Arifat discusses how to accomplish the new Mauritian government’s Vision 2030 strategy, his company’s successful track record as the main wholesaler and distributor of pharmaceuticals on the island, and the Mauritian business environment. As articulated in the Prime Minister’s recent Vision 2030 speech, the new government wants to…

Pharma Prof. Walter Ricciardi has just been appointed as the new president for the Italian National Institute of Health (ISS). He explains his priorities since taking office, the crucial role the ISS plays in the NHS and his vision for the future of the Italian National Healthcare System. Prof. Ricciardi, can…